Microsoft Stock Is Down More Than 10% In 3 Months. Time to Buy the Dip?

Microsoft's Azure and other cloud services revenue grew 40% year-over-year in fiscal Q1, while commercial remaining performance obligations rose over 50% to nearly $400 billion, signaling strong AI-driven demand; management guided Azure revenue growth of about 37% in constant currency for fiscal Q2 and said capacity constraints will persist through the fiscal year. Capital expenditures reached $34.9 billion in Q1 and management indicated capex growth will accelerate in fiscal 2026, pressuring margins (gross margin 69% in Q1) despite free cash flow of $25.7 billion (up 33% YoY). Given robust top-line momentum but higher spending and a near-term P/E around 33, the piece takes a cautious view on buying at current valuations.

Analysis

Market structure: Microsoft’s 40% Azure growth and >50% RPO expansion create clear winners — hyperscalers (MSFT), AI silicon providers (NVDA), and data‑center landlords (EQIX/COR) — while on‑prem incumbents and smaller clouds face accelerating share loss. Heavy capex ($34.9B last quarter and rising) signals persistent supply constraints for GPU/datacenter capacity, enabling short‑term pricing power but also compressing gross margins as usage scales.

Risk assessment: Key tail risks are GPU supply shock, a large enterprise contract pullback, or adverse antitrust action; any one could cut FY26 revenue growth >5–10% or force meaningful write‑downs. Timeline: expect earnings‑driven volatility in days, capacity/gross‑margin reharmonization over the next 3–12 months, and profit recovery or margin normalization over 12–36 months depending on capex payback; monitor RPO growth deceleration, gross margin delta >200bps, and NVIDIA inventory signals.

Trade implications: Primary actionable plays are a selective long MSFT exposure as a core AI‑cloud compounder plus levered exposure to NVDA and data‑center REITs; consider pair trades long MSFT vs short legacy cloud/software (ORCL) to hedge macro cloud risk. Options: monetize near‑term IV into earnings by selling 30–45 day ATM calls against part of a long position, and establish asymmetric upside with Jan 2027 LEAP call purchases if you want convexity without full equity risk.

Contrarian angle: The market is focusing on margin compression and elevated P/E (~33) while underweighting RPO locks — large contracted revenue (near $400B) creates visibility and switching costs that should support multiple expansion if supply constraints ease. Beware the opposite risk: excessive capex could create stranded capacity and write‑offs; IV is likely overpriced into earnings, so selling premium around the print is often favorable historically (AWS-era capex cycle parallels).

Key Decisions for Investors

• Establish a 2–3% portfolio long position in MSFT (6–12 month horizon). Add to 4–5% if shares drop another 8–12% or if fiscal Q2 Azure growth guidance remains ≥35% constant‑currency; trim if gross margin falls >200bps YoY.
• Initiate a 3% long MSFT / 3% short ORCL pair trade (6–12 months) to capture cloud share migration; rebalance if ORCL reports cloud revenue growth >15% or MSFT RPO growth decelerates by >20 ppt.
• Allocate 1–2% to NVDA as a levered hardware play (or buy 6–12 month call spreads sized to 1–2% notional) to play continued GPU tightness; scale out if NVDA reports meaningful inventory destocking or if trailing 3‑month sales slow >20%.
• If implied volatility spikes into MSFT earnings, sell 30–45 day ATM calls representing up to 50% of your MSFT long position to collect premium; simultaneously buy Jan 2027 LEAP calls (size ≤ 50% of equity exposure) to retain asymmetric upside without full delta exposure.
• Increase 1–2% allocation to data‑center REITs (EQIX, COR) over the next 3 months to capture structural demand from capex, and reduce 1–2% exposure to on‑prem enterprise tech (e.g., HPE/legacy hardware) which faces margin pressure from cloud migration.